RPG Life Sciences Q3 Results
- BSE: 532983
- NSE: RPGLIFE
- ISIN: INE105J01010
- Sector: Biotechnology & Drugs
BSE
2,640.00
-3.95 (-0.15%)
-3.95 (-0.15%)Volume377.00
Updated: Tue 11 Aug, 2026 | 15:24:05
NSE
2,637-1.00 (-0.04%)
-1.00 (-0.04%)Volume6.79 K
Updated: Tue 11 Aug, 2026 | 15:29:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - RPG Life Sciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 154.07 | 158.89 | 12.75% | 129.01 | 19.42% |
| Depreciation/ Amortization | 5.38 | 5.31 | 3.07% | 5.46 | -1.47% |
| Operating Income | 25.96 | 13.32 | -42.35% | 43.70 | -40.59% |
| Net Income | 22.13 | 4.20 | -39.95% | 34.93 | -36.64% |
| Other Operating Expenses Total | 40.05 | 39.02 | 0.35% | 38.73 | 3.41% |
| Net Income Before Taxes | 29.12 | 15.09 | -41.11% | 46.89 | -37.90% |
| Total Revenue | 180.03 | 172.21 | -0.91% | 172.71 | 4.24% |
| Selling/ General/ Admin Expenses Total | 35.32 | 33.09 | -2.32% | 28.71 | 23.02% |
| Diluted Normalized EPS | 17.25 | 13.27 | 0.14% | 21.12 | -18.33% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.